[1]
Brouwer S, Rivera-Hernandez T, Curren BF, Harbison-Price N, De Oliveira DMP, Jespersen MG, Davies MR, Walker MJ. Pathogenesis, epidemiology and control of Group A Streptococcus infection. Nature reviews. Microbiology. 2023 Jul:21(7):431-447. doi: 10.1038/s41579-023-00865-7. Epub 2023 Mar 9
[PubMed PMID: 36894668]
[2]
Dunne EM, Hutton S, Peterson E, Blackstock AJ, Hahn CG, Turner K, Carter KK. Increasing Incidence of Invasive Group A Streptococcus Disease, Idaho, USA, 2008-2019. Emerging infectious diseases. 2022 Sep:28(9):1785-1795. doi: 10.3201/eid2809.212129. Epub
[PubMed PMID: 35997313]
[3]
Ferretti JJ, Stevens DL, Fischetti VA, Stevens DL, Bryant AE. Streptococcus pyogenes Impetigo, Erysipelas, and Cellulitis. Streptococcus pyogenes: Basic Biology to Clinical Manifestations. 2022 Oct 8:():
[PubMed PMID: 36479753]
[4]
Martin JM, Green M. Group A streptococcus. Seminars in pediatric infectious diseases. 2006 Jul:17(3):140-8
[PubMed PMID: 16934708]
[5]
Oliver J, Malliya Wadu E, Pierse N, Moreland NJ, Williamson DA, Baker MG. Group A Streptococcus pharyngitis and pharyngeal carriage: A meta-analysis. PLoS neglected tropical diseases. 2018 Mar:12(3):e0006335. doi: 10.1371/journal.pntd.0006335. Epub 2018 Mar 19
[PubMed PMID: 29554121]
Level 1 (high-level) evidence
[6]
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C, Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Nov 15:55(10):e86-102. doi: 10.1093/cid/cis629. Epub 2012 Sep 9
[PubMed PMID: 22965026]
Level 1 (high-level) evidence
[7]
Carville KS, Meagher N, Abo YN, Manski-Nankervis JA, Fielding J, Steer A, McVernon J, Price DJ. Burden of antimicrobial prescribing in primary care attributable to sore throat: a retrospective cohort study of patient record data. BMC primary care. 2024 Apr 17:25(1):117. doi: 10.1186/s12875-024-02371-y. Epub 2024 Apr 17
[PubMed PMID: 38632513]
Level 2 (mid-level) evidence
[8]
Worrall G, Hutchinson J, Sherman G, Griffiths J. Diagnosing streptococcal sore throat in adults: randomized controlled trial of in-office aids. Canadian family physician Medecin de famille canadien. 2007 Apr:53(4):666-71
[PubMed PMID: 17872717]
Level 1 (high-level) evidence
[9]
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Nov 15:55(10):1279-82. doi: 10.1093/cid/cis847. Epub
[PubMed PMID: 23091044]
Level 1 (high-level) evidence
[10]
Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM Jr, Finkelstein JA, Gerber JS, Hyun DY, Linder JA, Lynfield R, Margolis DJ, May LS, Merenstein D, Metlay JP, Newland JG, Piccirillo JF, Roberts RM, Sanchez GV, Suda KJ, Thomas A, Woo TM, Zetts RM, Hicks LA. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016 May 3:315(17):1864-73. doi: 10.1001/jama.2016.4151. Epub
[PubMed PMID: 27139059]
[11]
Vannice KS, Ricaldi J, Nanduri S, Fang FC, Lynch JB, Bryson-Cahn C, Wright T, Duchin J, Kay M, Chochua S, Van Beneden CA, Beall B. Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to β-Lactam Antibiotics. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Jun 24:71(1):201-204. doi: 10.1093/cid/ciz1000. Epub
[PubMed PMID: 31630171]
[12]
DeMuri GP, Sterkel AK, Kubica PA, Duster MN, Reed KD, Wald ER. Macrolide and Clindamycin Resistance in Group a Streptococci Isolated From Children With Pharyngitis. The Pediatric infectious disease journal. 2017 Mar:36(3):342-344. doi: 10.1097/INF.0000000000001442. Epub
[PubMed PMID: 27902646]
[13]
Shaikh N, Swaminathan N, Hooper EG. Accuracy and precision of the signs and symptoms of streptococcal pharyngitis in children: a systematic review. The Journal of pediatrics. 2012 Mar:160(3):487-493.e3. doi: 10.1016/j.jpeds.2011.09.011. Epub 2011 Nov 1
[PubMed PMID: 22048053]
Level 1 (high-level) evidence
[14]
Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial Resistance. JAMA. 2016 Sep 20:316(11):1193-1204. doi: 10.1001/jama.2016.11764. Epub
[PubMed PMID: 27654605]
[15]
Gera K, McIver KS. Laboratory growth and maintenance of Streptococcus pyogenes (the Group A Streptococcus, GAS). Current protocols in microbiology. 2013 Oct 2:30():9D.2.1-9D.2.13. doi: 10.1002/9780471729259.mc09d02s30. Epub 2013 Oct 2
[PubMed PMID: 24510893]
[16]
Gherardi G, Vitali LA, Creti R. Prevalent emm Types among Invasive GAS in Europe and North America since Year 2000. Frontiers in public health. 2018:6():59. doi: 10.3389/fpubh.2018.00059. Epub 2018 Mar 9
[PubMed PMID: 29662874]
[17]
van Sorge NM, Cole JN, Kuipers K, Henningham A, Aziz RK, Kasirer-Friede A, Lin L, Berends ETM, Davies MR, Dougan G, Zhang F, Dahesh S, Shaw L, Gin J, Cunningham M, Merriman JA, Hütter J, Lepenies B, Rooijakkers SHM, Malley R, Walker MJ, Shattil SJ, Schlievert PM, Choudhury B, Nizet V. The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design. Cell host & microbe. 2014 Jun 11:15(6):729-740. doi: 10.1016/j.chom.2014.05.009. Epub
[PubMed PMID: 24922575]
[18]
Lancefield RC. THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS. The Journal of experimental medicine. 1928 Jan 1:47(1):91-103
[PubMed PMID: 19869404]
[19]
Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). Microbiology spectrum. 2019 Mar:7(2):. doi: 10.1128/microbiolspec.GPP3-0007-2018doi: 10.1128/microbiolspec.gpp3-0007-2018. Epub
[PubMed PMID: 30900541]
[20]
Sanderson-Smith M, De Oliveira DM, Guglielmini J, McMillan DJ, Vu T, Holien JK, Henningham A, Steer AC, Bessen DE, Dale JB, Curtis N, Beall BW, Walker MJ, Parker MW, Carapetis JR, Van Melderen L, Sriprakash KS, Smeesters PR, M Protein Study Group. A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. The Journal of infectious diseases. 2014 Oct 15:210(8):1325-38. doi: 10.1093/infdis/jiu260. Epub 2014 May 5
[PubMed PMID: 24799598]
Level 1 (high-level) evidence
[21]
Tagini F, Aubert B, Troillet N, Pillonel T, Praz G, Crisinel PA, Prod'hom G, Asner S, Greub G. Importance of whole genome sequencing for the assessment of outbreaks in diagnostic laboratories: analysis of a case series of invasive Streptococcus pyogenes infections. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2017 Jul:36(7):1173-1180. doi: 10.1007/s10096-017-2905-z. Epub 2017 Jan 26
[PubMed PMID: 28124734]
Level 2 (mid-level) evidence
[22]
Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, Sriprakash KS, Sanderson-Smith ML, Nizet V. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clinical microbiology reviews. 2014 Apr:27(2):264-301. doi: 10.1128/CMR.00101-13. Epub
[PubMed PMID: 24696436]
[23]
Atchade E, De Tymowski C, Grall N, Tanaka S, Montravers P. Toxic Shock Syndrome: A Literature Review. Antibiotics (Basel, Switzerland). 2024 Jan 18:13(1):. doi: 10.3390/antibiotics13010096. Epub 2024 Jan 18
[PubMed PMID: 38247655]
[24]
Avire NJ, Whiley H, Ross K. A Review of Streptococcus pyogenes: Public Health Risk Factors, Prevention and Control. Pathogens (Basel, Switzerland). 2021 Feb 22:10(2):. doi: 10.3390/pathogens10020248. Epub 2021 Feb 22
[PubMed PMID: 33671684]
[25]
Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalén C, Strep-EURO Study Group, Jasir A. Epidemiology of severe Streptococcus pyogenes disease in Europe. Journal of clinical microbiology. 2008 Jul:46(7):2359-67. doi: 10.1128/JCM.00422-08. Epub 2008 May 7
[PubMed PMID: 18463210]
[26]
Thompson KM, Sterkel AK, McBride JA, Corliss RF. The Shock of Strep: Rapid Deaths Due to Group a Streptococcus. Academic forensic pathology. 2018 Mar:8(1):136-149. doi: 10.23907/2018.010. Epub 2018 Mar 7
[PubMed PMID: 31240031]
[27]
Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren ML, Lynfield R, Aragon D, Zansky SM, Watt JP, Cieslak PR, Angeles K, Harrison LH, Petit S, Beall B, Van Beneden CA. Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Aug 15:63(4):478-86. doi: 10.1093/cid/ciw248. Epub 2016 Apr 22
[PubMed PMID: 27105747]
[28]
Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. The Lancet. Infectious diseases. 2005 Nov:5(11):685-94
[PubMed PMID: 16253886]
[30]
Bowen AC, Mahé A, Hay RJ, Andrews RM, Steer AC, Tong SY, Carapetis JR. The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma. PloS one. 2015:10(8):e0136789. doi: 10.1371/journal.pone.0136789. Epub 2015 Aug 28
[PubMed PMID: 26317533]
Level 1 (high-level) evidence
[31]
Bruun T, Oppegaard O, Kittang BR, Mylvaganam H, Langeland N, Skrede S. Etiology of Cellulitis and Clinical Prediction of Streptococcal Disease: A Prospective Study. Open forum infectious diseases. 2016 Jan:3(1):ofv181. doi: 10.1093/ofid/ofv181. Epub 2015 Nov 25
[PubMed PMID: 26734653]
[32]
Schmitz M, Roux X, Huttner B, Pugin J. Streptococcal toxic shock syndrome in the intensive care unit. Annals of intensive care. 2018 Sep 17:8(1):88. doi: 10.1186/s13613-018-0438-y. Epub 2018 Sep 17
[PubMed PMID: 30225523]
[33]
Arif N, Yousfi S, Vinnard C. Deaths from necrotizing fasciitis in the United States, 2003-2013. Epidemiology and infection. 2016 Apr:144(6):1338-44. doi: 10.1017/S0950268815002745. Epub 2015 Nov 9
[PubMed PMID: 26548496]
[34]
Katz AR, Morens DM. Severe streptococcal infections in historical perspective. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1992 Jan:14(1):298-307
[PubMed PMID: 1571445]
Level 3 (low-level) evidence
[35]
Factor SH, Levine OS, Schwartz B, Harrison LH, Farley MM, McGeer A, Schuchat A. Invasive group A streptococcal disease: risk factors for adults. Emerging infectious diseases. 2003 Aug:9(8):970-7
[PubMed PMID: 12967496]
[36]
Mehta S, McGeer A, Low DE, Hallett D, Bowman DJ, Grossman SL, Stewart TE. Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU. Chest. 2006 Dec:130(6):1679-86
[PubMed PMID: 17166982]
[37]
Vieira A, Wan Y, Ryan Y, Li HK, Guy RL, Papangeli M, Huse KK, Reeves LC, Soo VWC, Daniel R, Harley A, Broughton K, Dhami C, Ganner M, Ganner MA, Mumin Z, Razaei M, Rundberg E, Mammadov R, Mills EA, Sgro V, Mok KY, Didelot X, Croucher NJ, Jauneikaite E, Lamagni T, Brown CS, Coelho J, Sriskandan S. Rapid expansion and international spread of M1(UK) in the post-pandemic UK upsurge of Streptococcus pyogenes. Nature communications. 2024 May 10:15(1):3916. doi: 10.1038/s41467-024-47929-7. Epub 2024 May 10
[PubMed PMID: 38729927]
[38]
Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, Creti R, Ekelund K, Koliou M, Tassios PT, van der Linden M, Straut M, Vuopio-Varkila J, Bouvet A, Efstratiou A, Schalén C, Henriques-Normark B, Strep-EURO Study Group, Jasir A. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. Journal of clinical microbiology. 2009 Apr:47(4):1155-65. doi: 10.1128/JCM.02155-08. Epub 2009 Jan 21
[PubMed PMID: 19158266]
[39]
Zhi X, Li HK, Li H, Loboda Z, Charles S, Vieira A, Huse K, Jauneikaite E, Reeves L, Mok KY, Coelho J, Lamagni T, Sriskandan S. Emerging Invasive Group A Streptococcus M1(UK) Lineage Detected by Allele-Specific PCR, England, 2020(1). Emerging infectious diseases. 2023 May:29(5):1007-1010. doi: 10.3201/eid2905.221887. Epub 2023 Apr 5
[PubMed PMID: 37019153]
[40]
Lamagni T, Guy R, Chand M, Henderson KL, Chalker V, Lewis J, Saliba V, Elliot AJ, Smith GE, Rushton S, Sheridan EA, Ramsay M, Johnson AP. Resurgence of scarlet fever in England, 2014-16: a population-based surveillance study. The Lancet. Infectious diseases. 2018 Feb:18(2):180-187. doi: 10.1016/S1473-3099(17)30693-X. Epub 2017 Nov 27
[PubMed PMID: 29191628]
[41]
Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, Mosavie M, Pearson M, Asai M, Lobkowicz L, Chow JY, Parkhill J, Lamagni T, Chalker VJ, Sriskandan S. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. The Lancet. Infectious diseases. 2019 Nov:19(11):1209-1218. doi: 10.1016/S1473-3099(19)30446-3. Epub 2019 Sep 10
[PubMed PMID: 31519541]
Level 2 (mid-level) evidence
[42]
Li HK, Zhi X, Vieira A, Whitwell HJ, Schricker A, Jauneikaite E, Li H, Yosef A, Andrew I, Game L, Turner CE, Lamagni T, Coelho J, Sriskandan S. Characterization of emergent toxigenic M1(UK) Streptococcus pyogenes and associated sublineages. Microbial genomics. 2023 Apr:9(4):. doi: 10.1099/mgen.0.000994. Epub
[PubMed PMID: 37093716]
[43]
Starr CR, Engleberg NC. Role of hyaluronidase in subcutaneous spread and growth of group A streptococcus. Infection and immunity. 2006 Jan:74(1):40-8
[PubMed PMID: 16368955]
[44]
Heath A, DiRita VJ, Barg NL, Engleberg NC. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infection and immunity. 1999 Oct:67(10):5298-305
[PubMed PMID: 10496909]
[45]
Schroeder BM. Diagnosis and management of group A streptococcal pharyngitis. American family physician. 2003 Feb 15:67(4):880, 883-4
[PubMed PMID: 12613739]
[46]
Kanagasabai A, Evans C, Jones HE, Hay AD, Dawson S, Savović J, Elwenspoek MMC. Systematic review and meta-analysis of the accuracy of McIsaac and Centor score in patients presenting to secondary care with pharyngitis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2024 Apr:30(4):445-452. doi: 10.1016/j.cmi.2023.12.025. Epub 2024 Jan 3
[PubMed PMID: 38182052]
Level 1 (high-level) evidence
[47]
Hurst JR, Brouwer S, Walker MJ, McCormick JK. Streptococcal superantigens and the return of scarlet fever. PLoS pathogens. 2021 Dec:17(12):e1010097. doi: 10.1371/journal.ppat.1010097. Epub 2021 Dec 30
[PubMed PMID: 34969060]
[48]
Bellapianta JM, Ljungquist K, Tobin E, Uhl R. Necrotizing fasciitis. The Journal of the American Academy of Orthopaedic Surgeons. 2009 Mar:17(3):174-82
[PubMed PMID: 19264710]
[49]
Wang J, Zhou N, Xu B, Hao H, Kang L, Zheng Y, Jiang Y, Jiang H. Identification and cluster analysis of Streptococcus pyogenes by MALDI-TOF mass spectrometry. PloS one. 2012:7(11):e47152. doi: 10.1371/journal.pone.0047152. Epub 2012 Nov 7
[PubMed PMID: 23144803]
[50]
Cohen JF, Bertille N, Cohen R, Chalumeau M. Rapid antigen detection test for group A streptococcus in children with pharyngitis. The Cochrane database of systematic reviews. 2016 Jul 4:7(7):CD010502. doi: 10.1002/14651858.CD010502.pub2. Epub 2016 Jul 4
[PubMed PMID: 27374000]
Level 1 (high-level) evidence
[51]
Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerging infectious diseases. 1995 Jul-Sep:1(3):69-78
[PubMed PMID: 8903167]
[52]
Liu D, Hollingshead S, Swiatlo E, Lawrence ML, Austin FW. Rapid identification of Streptococcus pyogenes with PCR primers from a putative transcriptional regulator gene. Research in microbiology. 2005 May:156(4):564-7
[PubMed PMID: 15862455]
[53]
Barnett TC, Bowen AC, Carapetis JR. The fall and rise of Group A Streptococcus diseases. Epidemiology and infection. 2018 Aug 15:147():e4. doi: 10.1017/S0950268818002285. Epub 2018 Aug 15
[PubMed PMID: 30109840]
[54]
Macris MH, Hartman N, Murray B, Klein RF, Roberts RB, Kaplan EL, Horn D, Zabriskie JB. Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. The Pediatric infectious disease journal. 1998 May:17(5):377-81
[PubMed PMID: 9613649]
[55]
Yu D, Zheng Y, Yang Y. Is There Emergence of β-Lactam Antibiotic-Resistant Streptococcus pyogenes in China? Infection and drug resistance. 2020:13():2323-2327. doi: 10.2147/IDR.S261975. Epub 2020 Jul 14
[PubMed PMID: 32765008]
[56]
Rafei R, Al Iaali R, Osman M, Dabboussi F, Hamze M. A global snapshot on the prevalent macrolide-resistant emm types of Group A Streptococcus worldwide, their phenotypes and their resistance marker genotypes during the last two decades: A systematic review. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2022 Apr:99():105258. doi: 10.1016/j.meegid.2022.105258. Epub 2022 Feb 24
[PubMed PMID: 35219865]
Level 1 (high-level) evidence
[57]
Gergova R, Boyanov V, Muhtarova A, Alexandrova A. A Review of the Impact of Streptococcal Infections and Antimicrobial Resistance on Human Health. Antibiotics (Basel, Switzerland). 2024 Apr 15:13(4):. doi: 10.3390/antibiotics13040360. Epub 2024 Apr 15
[PubMed PMID: 38667036]
[58]
Sun L, Xiao Y, Huang W, Lai J, Lyu J, Ye B, Chen H, Gu B. Prevalence and identification of antibiotic-resistant scarlet fever group A Streptococcus strains in some paediatric cases at Shenzhen, China. Journal of global antimicrobial resistance. 2022 Sep:30():199-204. doi: 10.1016/j.jgar.2022.05.012. Epub 2022 May 23
[PubMed PMID: 35618209]
Level 3 (low-level) evidence
[59]
Johnson AF, LaRock CN. Antibiotic Treatment, Mechanisms for Failure, and Adjunctive Therapies for Infections by Group A Streptococcus. Frontiers in microbiology. 2021:12():760255. doi: 10.3389/fmicb.2021.760255. Epub 2021 Nov 4
[PubMed PMID: 34803985]
[60]
Stevens DL. Invasive group A streptococcal disease. Infectious agents and disease. 1996 Jun:5(3):157-66
[PubMed PMID: 8805078]
[61]
Stevens DL. Invasive group A streptococcus infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1992 Jan:14(1):2-11
[PubMed PMID: 1571429]
[62]
Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, Sable C, Steer A, Wilson N, Wyber R, Zühlke L. Acute rheumatic fever and rheumatic heart disease. Nature reviews. Disease primers. 2016 Jan 14:2():15084. doi: 10.1038/nrdp.2015.84. Epub 2016 Jan 14
[PubMed PMID: 27188830]